Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB

Authors: Dilinaer Bolati, Hidehisa Shimizu, Maimaiti Yisireyili, Fuyuhiko Nishijima, Toshimitsu Niwa

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Indoxyl sulfate, a uremic toxin, is accumulated in the serum of chronic kidney disease (CKD) patients, accelerating the progression of CKD. In CKD rat kidney, the expressions of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and its related genes are downregulated. AST-120, an oral sorbent, reduces serum indoxyl sulfate and slows the progression of CKD. The present study aimed to determine whether indoxyl sulfate downregulates Nrf2 expression in human proximal tubular cells and rat kidneys and whether AST-120 upregulates Nrf2 expression in CKD rat kidneys.

Methods

Effects of indoxyl sulfate on expression of Nrf2 were determined using HK-2 cells as human proximal tubular cells and the following animals: (1) Dahl salt-resistant normotensive rats (DN), (2) Dahl salt-resistant normotensive indoxyl sulfate-administered rats (DN+IS), (3) Dahl salt-sensitive hypertensive rats (DH), and (4) Dahl salt-sensitive hypertensive indoxyl sulfate-administered rats (DH+IS). Further, AST-120 was administered to subtotally nephrectomized CKD rats to determine its effect on the expression of Nrf2.

Results

Indoxyl sulfate downregulated Nrf2 expression in HK-2 cells. The indoxyl sulfate-induced downregulation of Nrf2 expression was alleviated by an inhibitor of nuclear factor-κB (NF-κB) (pyrrolidine dithiocarbamate) and small interfering RNA specific to NF-κB p65. DN+IS, DH, and DH+IS rats showed decreased renal expression of Nrf2 and its downstream target genes, heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1), and increased renal expression of 8-hydroxydeoxyguanosine (8-OHdG), a marker of reactive oxygen species (ROS), compared with DN. Thus, indoxyl sulfate, as well as hypertension, downregulated renal expression of Nrf2 in rats. AST-120 upregulated renal expression of Nrf2, HO-1 and NQO1 and suppressed renal expression of 8-OHdG compared with control CKD rats.

Conclusions

Indoxyl sulfate downregulates renal expression of Nrf2 through activation of NF-κB, followed by downregulation of HO-1 and NQO1 and increased production of ROS. Further, AST-120 upregulates renal expression of Nrf2 in CKD rats by removing serum indoxyl sulfate, followed by upregulation of HO-1 and NQO1 and decreased production of ROS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med. 1994, 124: 96-104.PubMed Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med. 1994, 124: 96-104.PubMed
2.
go back to reference Niwa T, Ise M, Miyazaki T: Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol. 1994, 14: 207-212. 10.1159/000168716.CrossRefPubMed Niwa T, Ise M, Miyazaki T: Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol. 1994, 14: 207-212. 10.1159/000168716.CrossRefPubMed
3.
go back to reference Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama I, Nakamura S, Endou H, Niwa T: Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol. 2002, 13: 1711-1720. 10.1097/01.ASN.0000022017.96399.B2.CrossRefPubMed Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama I, Nakamura S, Endou H, Niwa T: Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol. 2002, 13: 1711-1720. 10.1097/01.ASN.0000022017.96399.B2.CrossRefPubMed
4.
go back to reference Miyazaki T, Ise M, Seo H, Niwa T: Indoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and pro-α 1(I) collagen in uremic rat kidneys. Kidney Int. 1997, S62: S15-S22. Miyazaki T, Ise M, Seo H, Niwa T: Indoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and pro-α 1(I) collagen in uremic rat kidneys. Kidney Int. 1997, S62: S15-S22.
5.
go back to reference Miyazaki T, Ise M, Hirata M, Endo K, Ito Y, Seo H, Niwa T: Indoxyl sulfate stimulates renal synthesis of transforming growth factor-β1 and progression of renal failure. Kidney Int. 1997, S63: S211-S214. Miyazaki T, Ise M, Hirata M, Endo K, Ito Y, Seo H, Niwa T: Indoxyl sulfate stimulates renal synthesis of transforming growth factor-β1 and progression of renal failure. Kidney Int. 1997, S63: S211-S214.
6.
go back to reference Adijiang A, Shimizu H, Higuchi Y, Nishijima F, Niwa T: Indoxyl sulfate reduces klotho expression and promotes senescence in the kidneys of hypertensive rats. J Ren Nutr. 2011, 21: 105-109. 10.1053/j.jrn.2010.10.020.CrossRefPubMed Adijiang A, Shimizu H, Higuchi Y, Nishijima F, Niwa T: Indoxyl sulfate reduces klotho expression and promotes senescence in the kidneys of hypertensive rats. J Ren Nutr. 2011, 21: 105-109. 10.1053/j.jrn.2010.10.020.CrossRefPubMed
7.
go back to reference Bolati D, Shimizu H, Higashiyama Y, Nishijima F, Niwa T: Indoxyl sulfate induces epithelial-to-mesenchymal transition in rat kidneys and human proximal tubular cells. Am J Nephrol. 2011, 34: 318-323. 10.1159/000330852.CrossRefPubMed Bolati D, Shimizu H, Higashiyama Y, Nishijima F, Niwa T: Indoxyl sulfate induces epithelial-to-mesenchymal transition in rat kidneys and human proximal tubular cells. Am J Nephrol. 2011, 34: 318-323. 10.1159/000330852.CrossRefPubMed
8.
go back to reference Shimizu H, Bolati D, Adijiang A, Adelibieke Y, Muteliefu G, Enomoto A, Higashiyama Y, Higuchi Y, Nishijima F, Niwa T: Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-ĸB. Am J Nephrol. 2011, 33: 319-324. 10.1159/000324885.CrossRefPubMed Shimizu H, Bolati D, Adijiang A, Adelibieke Y, Muteliefu G, Enomoto A, Higashiyama Y, Higuchi Y, Nishijima F, Niwa T: Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-ĸB. Am J Nephrol. 2011, 33: 319-324. 10.1159/000324885.CrossRefPubMed
9.
go back to reference Shimizu H, Bolati D, Adijiang A, Enomoto A, Nishijima F, Dateki M, Niwa T: Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol Cell Physiol. 2010, 299: C1110-C1117. 10.1152/ajpcell.00217.2010.CrossRefPubMed Shimizu H, Bolati D, Adijiang A, Enomoto A, Nishijima F, Dateki M, Niwa T: Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol Cell Physiol. 2010, 299: C1110-C1117. 10.1152/ajpcell.00217.2010.CrossRefPubMed
10.
go back to reference Shimizu H, Bolati D, Adijiang A, Muteliefu G, Enomoto A, Nishijima F, Dateki M, Niwa T: NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol. 2011, 301: C1201-C1212. 10.1152/ajpcell.00471.2010.CrossRefPubMed Shimizu H, Bolati D, Adijiang A, Muteliefu G, Enomoto A, Nishijima F, Dateki M, Niwa T: NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol. 2011, 301: C1201-C1212. 10.1152/ajpcell.00471.2010.CrossRefPubMed
11.
go back to reference Shimizu H, Bolati D, Higashiyama Y, Nishijima F, Shimizu K, Niwa T: Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. Life Sci. 2012, 90: 525-530. 10.1016/j.lfs.2012.01.013.CrossRefPubMed Shimizu H, Bolati D, Higashiyama Y, Nishijima F, Shimizu K, Niwa T: Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. Life Sci. 2012, 90: 525-530. 10.1016/j.lfs.2012.01.013.CrossRefPubMed
12.
go back to reference Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H: ROS and PDGF-β receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol. 2009, 297: C389-C396. 10.1152/ajpcell.00206.2009.CrossRefPubMed Shimizu H, Hirose Y, Nishijima F, Tsubakihara Y, Miyazaki H: ROS and PDGF-β receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol. 2009, 297: C389-C396. 10.1152/ajpcell.00206.2009.CrossRefPubMed
13.
go back to reference Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, Maeda K: Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron. 1991, 57: 84-88. 10.1159/000186222.CrossRefPubMed Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, Maeda K: Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron. 1991, 57: 84-88. 10.1159/000186222.CrossRefPubMed
14.
go back to reference Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S: The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int. 1997, S62: S23-S28. Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S: The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int. 1997, S62: S23-S28.
15.
go back to reference Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-β1 in uraemic rat kidneys. Nephrol Dial Transplant. 2000, 15: 1773-1781. 10.1093/ndt/15.11.1773.CrossRefPubMed Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-β1 in uraemic rat kidneys. Nephrol Dial Transplant. 2000, 15: 1773-1781. 10.1093/ndt/15.11.1773.CrossRefPubMed
16.
go back to reference Adijiang A, Niwa T: An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats. Am J Nephrol. 2010, 31: 160-164. 10.1159/000264634.CrossRefPubMed Adijiang A, Niwa T: An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats. Am J Nephrol. 2010, 31: 160-164. 10.1159/000264634.CrossRefPubMed
17.
go back to reference Bolati D, Shimizu H, Niwa T: AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of chronic kidney disease rats. J Ren Nutr. 2012, 22: 176-180. 10.1053/j.jrn.2011.10.015.CrossRefPubMed Bolati D, Shimizu H, Niwa T: AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of chronic kidney disease rats. J Ren Nutr. 2012, 22: 176-180. 10.1053/j.jrn.2011.10.015.CrossRefPubMed
18.
go back to reference Kobayashi M, Yamamoto M: Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005, 7: 385-394. 10.1089/ars.2005.7.385.CrossRefPubMed Kobayashi M, Yamamoto M: Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 2005, 7: 385-394. 10.1089/ars.2005.7.385.CrossRefPubMed
20.
go back to reference Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N: Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol. 2008, 19: 1681-1691. 10.1681/ASN.2007101099.CrossRefPubMedPubMedCentral Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N: Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol. 2008, 19: 1681-1691. 10.1681/ASN.2007101099.CrossRefPubMedPubMedCentral
21.
go back to reference Kim YH, Hwang JH, Noh JR, Gang GT, Tadi S, Yim YH, Jeoung NH, Kwak TH, Lee SH, Kweon GR, Kim JM, Shong M, Lee IK, Lee CH: Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase. Free Radic Biol Med. 2012, 52: 880-888. 10.1016/j.freeradbiomed.2011.12.007.CrossRefPubMed Kim YH, Hwang JH, Noh JR, Gang GT, Tadi S, Yim YH, Jeoung NH, Kwak TH, Lee SH, Kweon GR, Kim JM, Shong M, Lee IK, Lee CH: Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase. Free Radic Biol Med. 2012, 52: 880-888. 10.1016/j.freeradbiomed.2011.12.007.CrossRefPubMed
22.
go back to reference Kim HJ, Vaziri ND: Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010, 298: F662-F671. 10.1152/ajprenal.00421.2009.CrossRefPubMed Kim HJ, Vaziri ND: Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010, 298: F662-F671. 10.1152/ajprenal.00421.2009.CrossRefPubMed
23.
go back to reference Niwa T, Takeda N, Tatematsu A, Maeda K: Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem. 1988, 34: 2264-2267.PubMed Niwa T, Takeda N, Tatematsu A, Maeda K: Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem. 1988, 34: 2264-2267.PubMed
24.
go back to reference Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T: Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant. 2008, 23: 1892-1901. 10.1093/ndt/gfm861.CrossRefPubMed Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T: Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant. 2008, 23: 1892-1901. 10.1093/ndt/gfm861.CrossRefPubMed
25.
go back to reference Kwak MK, Itoh K, Yamamoto M, Kensler TW: Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the Nrf2 promoter. Mol Cell Bio. 2002, 22: 2883-2892. 10.1128/MCB.22.9.2883-2892.2002.CrossRef Kwak MK, Itoh K, Yamamoto M, Kensler TW: Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the Nrf2 promoter. Mol Cell Bio. 2002, 22: 2883-2892. 10.1128/MCB.22.9.2883-2892.2002.CrossRef
26.
go back to reference Yu M, Li H, Liu Q, Liu F, Tang L, Li C, Yuan Y, Zhan Y, Xu W, Li W, Chen H, Ge C, Wang J, Yang X: Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal. 2011, 23: 883-892. 10.1016/j.cellsig.2011.01.014.CrossRefPubMed Yu M, Li H, Liu Q, Liu F, Tang L, Li C, Yuan Y, Zhan Y, Xu W, Li W, Chen H, Ge C, Wang J, Yang X: Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signal. 2011, 23: 883-892. 10.1016/j.cellsig.2011.01.014.CrossRefPubMed
27.
go back to reference Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, Cimino F: p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem. 2006, 281: 39776-39784. 10.1074/jbc.M605707200.CrossRefPubMed Faraonio R, Vergara P, Di Marzo D, Pierantoni MG, Napolitano M, Russo T, Cimino F: p53 suppresses the Nrf2-dependent transcription of antioxidant response genes. J Biol Chem. 2006, 281: 39776-39784. 10.1074/jbc.M605707200.CrossRefPubMed
28.
go back to reference Pergola PE, Krauth M, Huff JW, Ferguson DA, Ruiz S, Meyer CJ, Warnock DG: Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am J Nephrol. 2011, 33: 469-476. 10.1159/000327599.CrossRefPubMed Pergola PE, Krauth M, Huff JW, Ferguson DA, Ruiz S, Meyer CJ, Warnock DG: Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am J Nephrol. 2011, 33: 469-476. 10.1159/000327599.CrossRefPubMed
29.
go back to reference Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG, BEAM Study Investigators: Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011, 365: 327-336. 10.1056/NEJMoa1105351.CrossRefPubMed Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG, BEAM Study Investigators: Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011, 365: 327-336. 10.1056/NEJMoa1105351.CrossRefPubMed
Metadata
Title
Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB
Authors
Dilinaer Bolati
Hidehisa Shimizu
Maimaiti Yisireyili
Fuyuhiko Nishijima
Toshimitsu Niwa
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-56

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.